Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the…
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had ret…
(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncol…
(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncol…